Why the study?
The COOL-AF risk scores for death, bleeding, and thromboembolic events were derived from a Thai cohort and required external validation.
Do the COOL-AF risk scores accurately predict death, bleeding, and thromboembolic events in Asian and European patients with atrial fibrillation?
Do the COOL-AF risk scores accurately predict death, bleeding, and thromboembolic events in Asian and European patients with atrial fibrillation?
The COOL-AF risk score is a valid tool for predicting death and major bleeding in Asian patients with atrial fibrillation, demonstrating better performance in Asian compared to European cohorts.
Answers are grounded in this paper and cite their sources.
May support COOL-AF for risk stratification in Asian AF patients; leaves open prospective validation and outcome impact.
Background: The COOL-AF (Cohort of Antithrombotic Use and Optimal International Normalized Ratio Levels in Patients with Atrial Fibrillation) risk scores for death, bleeding, and thromboembolic events (TEs) were derived from the COOL-AF cohort from Thailand and require external validation. Objectives: The authors sought to externally validate the COOL-AF scores in the APHRS (Asia-Pacific Heart Rhythm Society) registry and to compare their performance in the ESC-EHRA (European Society of Cardiology-European Heart Rhythm Association) EORP-AF (EURObservational Research Programme in Atrial Fibrillation) General Long-Term Registry. Conclusions: The COOL-AF risk scores may be an easy tool to identify Asian patients with AF at risk for death and major bleeding and performs better in Asian than in European patients with AF. (Clinical Survey on the Stroke Prevention in Atrial Fibrillation in Asia [AF-Registry]; NCT04807049).
No takes yet. Share an insight, caveat, or question.
Bucci et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: